Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.69
-0.7%
$1.03
$0.64
$1.90
$51.76M0.94372,147 shs288,694 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.90
-2.2%
$1.08
$0.54
$1.39
$70.10M1.41135,220 shs37,862 shs
TELA Bio, Inc. stock logo
TELA
TELA Bio
$1.02
-12.8%
$2.30
$1.02
$6.50
$40.18M0.98233,405 shs1.46 million shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$0.23
-6.7%
$0.32
$0.22
$1.74
$15.76M0.15929,988 shs1.01 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-6.01%-11.15%-25.72%-34.83%-30.92%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-7.07%-14.81%-17.12%-3.16%+45.99%
TELA Bio, Inc. stock logo
TELA
TELA Bio
-6.40%-14.60%-50.00%-59.79%-77.92%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-2.35%-12.70%-9.11%-31.83%-84.47%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hyperfine, Inc. stock logo
HYPR
Hyperfine
3.0687 of 5 stars
3.35.00.00.01.12.51.3
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
1.713 of 5 stars
3.50.00.00.02.31.70.0
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.3857 of 5 stars
3.44.00.00.01.71.70.6
Beyond Air, Inc. stock logo
XAIR
Beyond Air
4.2799 of 5 stars
3.55.00.03.50.03.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.67
Moderate Buy$1.3393.88% Upside
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.2538.89% Upside
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.75
Moderate Buy$7.25610.78% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.00
Buy$3.671,501.16% Upside

Current Analyst Ratings Breakdown

Latest XAIR, TELA, HYPR, and MLSS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/24/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$1.50
3/21/2025
TELA Bio, Inc. stock logo
TELA
TELA Bio
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $7.00
3/21/2025
TELA Bio, Inc. stock logo
TELA
TELA Bio
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$5.00 ➝ $2.00
3/20/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$1.50 ➝ $1.20
3/18/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$1.10 ➝ $1.29
(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$12.89M4.14N/AN/A$1.17 per share0.59
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$8.88M7.90N/AN/A$0.11 per share8.18
TELA Bio, Inc. stock logo
TELA
TELA Bio
$69.30M0.58N/AN/A$0.77 per share1.32
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.02M5.21N/AN/A$0.27 per share0.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$44.24M-$0.56N/AN/AN/A-309.42%-57.54%-50.38%5/12/2025 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.07N/AN/A-52.01%-60.26%-40.23%N/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$46.66M-$1.39N/AN/AN/A-60.49%-556.18%-63.13%5/8/2025 (Estimated)
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$60.24M-$1.06N/AN/AN/A-1,730.00%-226.01%-109.75%6/23/2025 (Estimated)

Latest XAIR, TELA, HYPR, and MLSS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/20/2025Q4 2024
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.24-$0.23+$0.01-$0.23$23.17 million$17.65 million
3/17/2025Q4 2024
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.16-$0.14+$0.02-$0.14$2.30 million$2.32 million
2/10/2025Q3 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.24-$0.15+$0.09-$0.15$0.93 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/A
6.44
5.73
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
TELA Bio, Inc. stock logo
TELA
TELA Bio
14.22
2.62
1.81
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/A
3.56
3.12

Institutional Ownership

CompanyInstitutional Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
TELA Bio, Inc. stock logo
TELA
TELA Bio
94.35%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
29.42%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
24.75%
TELA Bio, Inc. stock logo
TELA
TELA Bio
6.00%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
20.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
19077.83 million51.49 millionOptionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3077.89 million58.61 millionOptionable
TELA Bio, Inc. stock logo
TELA
TELA Bio
12039.39 million37.03 millionOptionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7068.80 million54.97 millionOptionable

Recent News About These Companies

Beyond Air subsidiary NeuroNOS announces publication of research
Beyond Air announces VUMC as first luminary site
Beyond Air Expands Global Reach for LungFit PH
Beyond Air (XAIR) Receives a Hold from BTIG
Piper Sandler Sticks to Their Buy Rating for Beyond Air (XAIR)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.69 0.00 (-0.69%)
As of 12:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.90 -0.02 (-2.17%)
As of 12:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

TELA Bio stock logo

TELA Bio NASDAQ:TELA

$1.02 -0.15 (-12.82%)
As of 12:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$0.23 -0.02 (-6.68%)
As of 12:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.